Sperling Prostate Center

(877) 605-2737
  • Request Consultation
  • Español
Minimally invasive prostate cancer and BPH treatments
  • About SPC
    About SPC

    The Sperling Prostate Center in New York City and Florida is a technologically-advanced, patient-oriented practice dedicated to providing the most effective techniques in prostate cancer diagnosis and treatment. Learn more

    • Meet Dr. Sperling
    • Patient Testimonials
    • News
  • Screening & Detection
    Screening & Detection

    The Sperling Prostate Center’s state-of-the-art BlueLaser™ MRI imaging reveals an image of the prostate that can’t be captured by standard biopsy or ultrasound, allowing us to identify and target tumors with unparalleled precision. Learn more

    • 3T Multi-Parametric MRI – BlueLaser™
    • MRI-Guided Biopsy
    • mpMRI for More Effective Active Surveillance
    • Genomic Prostate Cancer Testing
    • Prostatitis and CPPS Diagnosis
  • Treatment
    Treatment

    We offer a revolutionary suite of therapies for prostate cancer and other conditions, based on our advanced, minimally-invasive BlueLaser™ system, available exclusively at Sperling Prostate Center. Learn more

    • Focal Laser Ablation for Prostate Cancer
    • Focal Laser Treatment for BPH
    • mpMRI for More Effective Active Surveillance
    • mpMRI for Testosterone Replacement Therapy Patients
  • Nutrition
  • Patient Portal
    Patient Portal

    At Sperling Prostate Center, we strive to make every patient feel comfortable, educated, and in control. Here you’ll find a variety of ways to make your visit easier and your personal journey smoother. Learn more

    • New Patient Forms & Information
    • Articles & Research on Prostate Cancer and Men’s Health
    • MRI Second Opinion Upload
    • Glossary
  • Blog
  • Contact

Category: Focal Treatment & Laser Ablation

  • November 12, 2014
  • Focal Treatment & Laser Ablation

Prostate Cancer Treatment Trends: Where is Focal Therapy?

Focal Prostate Imaging
The CaPSURE registry (Cancer of the Prostate Strategic Urologic Research Endeavor) is a remarkable ongoing collection of information about prostate cancer patients drawn from 36 clinical sites that participate in this endeavor. Currently, data on more than 13,000 men exists in CaPSURE. While their identities are protected, information on factors such as date of diagnosis, keep reading
Previous page 1 2 3
connect & follow
Get our newsletter

The latest research and insights on prostate health, men's wellness, and living your fullest life

Success! Please be sure to add prostatecenter@sperlingmedical.com to your contacts to ensure you always receive our articles and news.

Daily inspiration

Search the spc blog

Connect & Follow

Newsletter Signup

Sign up for our weekly newsletter on prostate wellness and men's health.

Success! Please be sure to add prostatecenter@sperlingmedical.com to your contacts to ensure you always receive our articles, updates, and news.

Featured Video

Sperling Prostate Center
Minimally invasive prostate cancer and BPH treatments
  • ASLMS
  • SAR
  • ABR
  • SUR
This content is solely for informational purposes and does not substitute for diagnostic or medical advice. Talk to your doctor or contact us if you have questions or concerns of a personal, medical nature.
© 2020 Sperling Radiology / Sperling Medical Group. All Rights Reserved. Read our Privacy Policy.

This content is solely for informational purposes and does not substitute for diagnostic or medical advice. Talk to your doctor or contact us if you have questions or concerns of a personal, medical nature. This site uses cookies to analyze traffic and user behavior, protect your privacy, and provide you with the best user experience. Learn more. 
close-image
An update on COVID-19: Your health and safety are our top priority.
Learn More
close-image
WordPress Image Lightbox

Sperling Prostate Center

Once we receive this secure information, a member of our team will be in touch with you as soon as possible to schedule your consultation.
  • This field is for validation purposes and should be left unchanged.